Category: biotech

.After antibody-drug conjugate (ADC) professional Seagen was sold to Pfizer in 2013 for a whopping $43 billion, former chief executive officer David Epstein stated he

.Among the genetic medications branches race, Front runner Pioneering is actually introducing a brand new firm to assist biotechs fine-tune the accuracy of their treatments.The

.Tough Biotech Associate Editor Gabrielle Masson provided the 2024 lesson of Ferocious 15 champions on the floor of the Stock exchange on Wednesday.Masson seemed on

.Permit’s study a conversation along with Ayla Ellison, Strong Biotech Editor-in-Chief as well as Michelle Benz as they discuss the highlights and also enjoyment neighboring

.FibroGen is actually significantly restructuring its business, laying off 75% of its own united state personnel and quiting investment in its lead prospect in feedback

.After F2G’s 1st effort to get a new lesson of antifungal to market was actually hindered by the FDA, the U.K.-based biotech has actually secured

.Five months after signing off on Power Therapeutics’ Pivya as the 1st brand-new therapy for easy urinary system tract diseases (uUTIs) in greater than twenty

.The FDA has executed a partial hang on a stage 3 non-small cell lung cancer practice run by BioNTech and also OncoC4 after seeing differing

.The FDA has positioned Kezar Lifestyle Sciences’ lupus trial on hold after the biotech warned 4 fatalities in the course of the phase 2b research.Kezar

.After pushing back the choice date for Applied Rehabs’ metabolic ailment medicine govorestat, the FDA has actually right now chosen that a prepared advisory board